(NCBI) That distinction matters
This article examines the current evidence, explores possible mechanisms linking metabolic and mental health, and provides guidance on discussing anxiety concerns with your GP if you are considering or taking GLP-1 treatment
Notably, the US FDA submission documents for tirzepatide include predictions of DDIs mediated by delayed gastric emptying using PBPK modeling, rather than conducting clinical DDI studies for certain drugs (Table 6)
Despite ongoing research, many aspects of this complex metabolic disease are still not well understood
What Happens After FDA Approval Even after FDA approval, there are several steps before retatrutide becomes widely available: Prescriptions and Availability Lilly will need to scale manufacturing, which typically begins well before approval Initial supply may be limited, similar to the early availability challenges seen with Mounjaro and Zepbound Prescriptions will initially require an in-person or telehealth consultation with a licensed provider Insurance Coverage Insurance coverage is not automatic upon FDA approval Private insurers will set their own coverage policies, which can take months to finalize Medicare and Medicaid coverage depends on the approved indication and ongoing policy decisions The Medicare Inflation Reduction Act drug price negotiation program may eventually apply Pricing Context Current GLP-1 drug pricing provides context for what retatrutide might cost, though Lilly has not announced pricing: GoodRx has offered introductory pricing of $199/month for certain GLP-1 medications
